Apellis Pharmaceuticals Inc PEG
What is the PEG of Apellis Pharmaceuticals Inc?
The PEG of Apellis Pharmaceuticals Inc is N/A
What is the definition of PEG?
Price/earnings to growth (PEG) ratio is a stock’s P/E ratio divided by a predicted growth rate of its earnings for a time period of 5 years.
= forward PE / 5-year EPS growth rate
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG of companies in the Health Care sector on NASDAQ compared to Apellis Pharmaceuticals Inc
What does Apellis Pharmaceuticals Inc do?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Companies with peg similar to Apellis Pharmaceuticals Inc
- Cincinnati Bell has PEG of N/A
- BE Semiconductor Industries NV has PEG of N/A
- Amneal Pharmaceuticals Inc has PEG of N/A
- Rosetta Stone has PEG of N/A
- GSI Technology Inc has PEG of N/A
- Magma Fincorp has PEG of N/A
- Apellis Pharmaceuticals Inc has PEG of N/A
- Scholastic has PEG of N/A
- Nautilus Inc has PEG of N/A
- Euroseas Ltd has PEG of N/A
- Nevro Corp has PEG of N/A
- Amarin Corp has PEG of N/A
- Transcontinental has PEG of N/A